| Predicate |
Object |
| contentType |
Journal Article|Review |
| endingPage |
134 |
| issn |
0920-1211 |
| issueIdentifier |
2 |
| pageRange |
95-134 |
| publicationName |
Epilepsy Research |
| startingPage |
95 |
| bibliographicCitation |
Löscher W, Schmidt D. Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation? Epilepsy Res. 1994 Feb;17(2):95–134. doi: 10.1016/0920-1211(94)90012-4. PMID: 8194514. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5da7e445c75e1c3cf4cae02484c369b6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f55585f3a8d1486c97030eaf4af6917f |
| date |
199402 |
| identifier |
https://doi.org/10.1016/0920-1211%2894%2990012-4
https://pubmed.ncbi.nlm.nih.gov/8194514 |
| isPartOf |
https://portal.issn.org/resource/ISSN/0920-1211
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3587 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation? |
| discusses |
http://id.nlm.nih.gov/mesh/M0001382 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D004353
http://id.nlm.nih.gov/mesh/D015195
http://id.nlm.nih.gov/mesh/D000927Q000494 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000927Q000737
http://id.nlm.nih.gov/mesh/D000818 |